Evidence map›Paper›PMID 31431533›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Runx1 promotes murine erythroid progenitor proliferation and inhibits differentiation by preventing Pu.1 downregulation.

Michael A Willcockson, Samuel J Taylor, Srikanta Ghosh, Sean E Healton, Justin C Wheat, Tommy J Wilson, Ulrich Steidl, Arthur I Skoultchi

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. RUNX1 Upregulates CENPE to Promote Leukemic Cell Proliferation.Frontiers in molecular biosciences · 2021
    Article
  14. Human yolk sac-like haematopoiesis generatesDevelopment (Cambridge, England) · 2020
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Michael A WillcocksonDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461; michael.willcockson@med.einstein.yu.edu arthur.skoultchi@einstein.yu.edu.ORCID 0000-0001-6710-1293
Samuel J TaylorDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461.
Srikanta GhoshDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461.
Sean E HealtonDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461.
Justin C WheatDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461.
Tommy J WilsonDepartment of Neurology, Columbia University College of Physicians and Surgeons, Columbia University Medical Center, New York Presbyterian Hospital, New York, NY 10032.
Ulrich SteidlDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461.
Arthur I SkoultchiDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461; michael.willcockson@med.einstein.yu.edu arthur.skoultchi@einstein.yu.edu.
Albert Einstein College of Medicine · USNewYork–Presbyterian Hospital · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
Mechanisms of Formation and Progression of Preleukemic Stem CellsR01CA217092 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STEIDL, ULRICH · 2017 to 2021
$2.0M
Control of the Erythroid Terminal Differentiation DecisionR01DK096266 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SKOULTCHI, ARTHUR I · 2012 to 2016
$1.8M
NCI NIH HHS P30 CA013330NCI NIH HHS R01 CA217092NIDDK NIH HHS R01 DK096266
6 · The paper itself

Abstract

Pu.1 is an ETS family transcription factor (TF) that plays critical roles in erythroid progenitors by promoting proliferation and blocking terminal differentiation. However, the mechanisms controlling expression and down-regulation of Pu.1 during early erythropoiesis have not been defined. In this study, we identify the actions of Runx1 and Pu.1 itself at the Pu.1 gene Upstream Regulatory Element (URE) as major regulators of Pu.1 expression in Burst-Forming Unit erythrocytes (BFUe). During early erythropoiesis, Runx1 and Pu.1 levels decline, and chromatin accessibility at the URE is lost. Ectopic expression of Runx1 or Pu.1, both of which bind the URE, prevents Pu.1 down-regulation and blocks terminal erythroid differentiation, resulting in extensive ex vivo proliferation and immortalization of erythroid progenitors. Ectopic expression of Runx1 in BFUe lacking a URE fails to block terminal erythroid differentiation. Thus, Runx1, acting at the URE, and Pu.1 itself directly regulate Pu.1 levels in erythroid cells, and loss of both factors is critical for Pu.1 down-regulation during terminal differentiation. The molecular mechanism of URE inactivation in erythroid cells through loss of TF binding represents a distinct pattern of Pu.1 regulation from those described in other hematopoietic cell types such as T cells which down-regulate Pu.1 through active repression. The importance of down-regulation of Runx1 and Pu.1 in erythropoiesis is further supported by genome-wide analyses showing that their DNA-binding motifs are highly overrepresented in regions that lose chromatin accessibility during early erythroid development.

Indexed as

Gene Expression RegulationAnimalsCell DifferentiationChromatinCore Binding Factor Alpha 2 SubunitErythroid Precursor CellsErythropoiesisMiceProto-Oncogene ProteinsProto-Oncogene Protein Spi-1RAW 264.7 CellsResponse ElementsTrans-ActivatorsTranscription, GeneticChromatinCore Binding Factor Alpha 2 SubunitProto-Oncogene ProteinsProto-Oncogene Protein Spi-1Runx1 protein, mouseTrans-Activatorserythropoiesisgene regulationPu.1Runx1transcription

Identifiers

PMID31431533
PMCPMC6731665
OpenAlexW2969832526

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.